McGowen Kerry, Funck Tobias, Wang Xin, Zinga Samuel, Wolf Ian D, Akusobi Chidiebere C, Denkinger Claudia M, Rubin Eric J, Sullivan Mark R
Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, USA.
Department of Infectious Disease and Tropical Medicine, Heidelberg University Hospital & German Center of Infection Research partner site, Germany.
bioRxiv. 2024 Aug 24:2024.08.23.609441. doi: 10.1101/2024.08.23.609441.
is a pulmonary pathogen that exhibits intrinsic resistance to antibiotics, but the factors driving this resistance are incompletely understood. Insufficient intracellular drug accumulation could explain broad-spectrum resistance, but whether antibiotics fail to accumulate in and the mechanisms required for drug exclusion remain poorly understood. We measured antibiotic accumulation in using mass spectrometry and found a wide range of drug accumulation across clinically relevant antibiotics. Of these compounds, linezolid accumulates the least, suggesting that inadequate uptake impacts its efficacy. We utilized transposon mutagenesis screening to identify genes that cause linezolid resistance and found multiple transporters that promote membrane permeability or efflux, including an uncharacterized, -specific protein that effluxes linezolid and several chemically related antibiotics. This demonstrates that membrane permeability and drug efflux are critical mechanisms of antibiotic resistance in and suggests that targeting membrane transporters could potentiate the efficacy of certain antibiotics.
是一种对抗生素表现出内在抗性的肺部病原体,但导致这种抗性的因素尚未完全明确。细胞内药物积累不足可能解释其广谱抗性,但抗生素是否无法在细胞内积累以及药物外排所需的机制仍知之甚少。我们使用质谱法测量了细胞内的抗生素积累情况,发现在临床相关抗生素中药物积累范围广泛。在这些化合物中,利奈唑胺积累最少,这表明摄取不足影响了其疗效。我们利用转座子诱变筛选来鉴定导致利奈唑胺抗性的基因,发现了多个促进膜通透性或外排的转运蛋白,包括一种未表征的、特定的蛋白,它能外排利奈唑胺和几种化学相关抗生素。这表明膜通透性和药物外排是该病原体抗生素抗性的关键机制,并表明靶向膜转运蛋白可能增强某些抗生素的疗效。